Cytokeratin 17 Primary Antibodies

Cytokeratin 17 Novocastra

Human squamous cell carcinoma, floor of the mouth: immunohistochemical staining for cytokeratin 17 using NCL-CK17. Note cytoplasmic staining of malignant cells. Paraffin section.
Human squamous cell carcinoma, floor of the mouth: immunohistochemical staining for cytokeratin 17 using NCL-CK17. Note cytoplasmic staining of malignant cells. Paraffin section.

Antigen Background

In normal tissues cytokeratin 17 is reported to be expressed in basal cells of complex epithelia, eg basal cells of pseudostratified epithelium in the trachea, larynx, bronchi, myoepithelial cells in salivary glands and sweat glands. In neoplastic tissue, cytokeratin 17 is reported to be expressed in squamous cell carcinomas of the lung, cervix and oral cavity.

Product Specific Information

NCL-CK17 reacts with the human cytokeratin intermediate filament protein (46 kD) identified as cytokeratin 17.


loading...

CLONE: E3

Material with code "Cytokeratin 17" is discontinued , possible alternatives:

製品の注文はこちら

商品番号 商品名 Configuration Use Datasheet MSDS 数量
PA0114 7ml Cytokeratin 17 Bond RTU Primary Bond ready to use reagent P(HIER) Info MSDS 1
CK17-L-CE 1ml NCL-L-CK17 Liquid Concentrated Monoclonal Antibody P(HIER) Info MSDS 1
CK17-L-U 1ml NCL-L-CK17 Liquid Concentrated Monoclonal Antibody P(HIER) Info MSDS 1
CK17-U 1ml NCL-CK17 US IVD Lyophilised Concentrated Monoclonal Antibody F, P(HIER), W MSDS 1
CK17 1ml NCL-CK17 Lyophilised Concentrated Monoclonal Antibody F, P(HIER), W Info MSDS 1
CK17-S 0.1ml NCL-CK17 Lyophilised Concentrated Monoclonal Antibody F, P(HIER), W Info MSDS 1